Amarin Corp Plc (AMRN)

[Number sleven]

BBI, Investing in a company because you expect it to be sold is unwise. This company has a valuable product and a long runway to capitalize on that value. I haven't listened to the investor conference yet. I have no opinion about it. Most biotech investors have the attention span of a meth head hummingbird. I think the remainder of 2024 is going to be painful. Institutions don't have a compelling reason to commit resources at the moment. I intend to accumulate shares when I can.
Good luck.
Sleven,